HEPLISAV-B

hepatitis B vaccine, adjuvanted · Dynavax Technologies Corporation

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for HEPLISAV-B, covering 2020-12-16 to 2026-01-28. Get the full timeline:

Most recent: EMA Authorised: Heplisav B (hepatitis B surface antigen) — Dynavax GmbH